Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
SMP$37.35-0.23(-0.61%)Standard Motor Products Expands Climate Control Portfolio with New Line of OE-Engineered A/C Condensers Standard Motor Products, Inc. (SMP), through its Temperature Control Division and flagship Four Seasons® brand, has introduced a comprehensive line...[10:00:00 AM ET]REAL$11.06+0.07(+0.64%)The RealReal Appoints Alexis Hoopes as Chief Merchandising Officer The RealReal (Nasdaq: REAL), the world's largest online marketplace for authenticated resale luxury goods, today announced the appointment of Alexis...[10:00:00 AM ET]FCNCA$2,360.97+5.46(+0.23%)First Citizens Bank Opens New Banking Office and Branch in Downtown Santa Monica First Citizens Bank today announced the opening of a new banking office and branch in Santa Monica, Calif. Located at 1540 2nd Street, the...[10:00:00 AM ET]PGNY$28.35+0.63(+2.27%)New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits[9:51:41 AM ET]CAE$25.71-0.03(-0.12%)New Horizons Ahead: Applications Open November 1 for the Eighth Annual Air Canada and CAE Captain Judy Cameron Scholarship (NASDAQ: CAE) (TSX: CAE) – Air Canada and CAE are once again joining forces to support more women building careers in aviation through the Captain...[9:43:00 AM ET]AFL$121.28-0.71(-0.58%)My Special Aflac Duck® Puts Love and Care in the hands of Children at Riley Hospital Children receiving care for cancer and blood disorders at Riley Hospital for Children in Indianapolis have a new companion to help bring comfort and...[9:40:00 AM ET]GMAB$51.89+7.21(+16.15%)Genmab Announces Statistically Significant, Clinically Meaningful Improvement in Overall Survival and Objective Response with Petosemtamab Combination at First Interim Analysis in First-Line R/M Patients with PD-L1+ Head and Neck Cancer[9:40:00 AM ET]ETD$19.95+0.03(+0.15%)Doug Bergeron Identifies Proven Retail Operator Stefanie Tsen Ward as Interim CEO Candidate for Ethan Allen[9:30:00 AM ET]FGPR$20.21+0.01(+0.05%)Ferrellgas and Operation Warm to Give More Than 350 Flagstaff Children New Winter Coats[9:30:00 AM ET]FGPR$20.21+0.01(+0.05%)Ferrellgas and Operation Warm to Give 350 Bay City Children New Winter Coats[9:30:00 AM ET]JXN$133.93-1.13(-0.84%)QVT Issues Second Report on Jackson Financial (JXN) Subsidiary Brooke Life Reinsurance Co. Underscoring Near-Term Liquidity Challenges[9:30:00 AM ET]APH$80.12+1.91(+2.44%)Industrial Growth Partners Announces Sale of AdvancedPCB Industrial Growth Partners ("IGP") is pleased to announce that it has entered into a definitive agreement to sell AdvancedPCB Holdings, LLC...[9:27:00 AM ET]BLGO$0.06-0.01(-7.25%)BioLargo Introduces barebird, a Company-Owned Brand, Reuniting Key Teams Behind Pooph's Consumer Market Success[9:25:00 AM ET]TWOSF$0.24-0.00(-0.04%)T2 Metals to Attend the 52nd Annual New Orleans Investment Conference[9:25:00 AM ET]MOB$3.36+0.07(+2.13%)Mobilicom to Showcase Cybersecure Portfolio Highlighting Newly Launched SwarmiX at ARC WEPTAC Conference[9:22:00 AM ET]

OPK · NASDAQ

OPKO Health, Inc.

$1.64 +0.03 (+1.55%)

Company overview

OPKO Health, Inc. is a healthcare company operating in diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Its Diagnostics segment operates BioReference Laboratories, which provides laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare services to physician offices, clinics, hospitals, employers, and governmental units. It also offers a novel diagnostic instrument system for point-of-care blood test results and 4Kscore prostate cancer testing services.

Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Market cap
$1.2B
Employees
2,997
Headquarters
Miami, FL
Website
opko.com
CEO
Phillip Frost
Listed
November 2, 1995
P/E
-5.96
Dividend yield
0.00%

Company financials

Revenue
$581M
Gross profit
$132M
Operating income
-$203M
EBITDA
-$112M
Net income
-$213M
EPS
-$0.28
Total assets
$1.9B
Total debt
$397M
Gross margin
22.73%
Net margin
-36.64%
Earnings yield
-16.79%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

0.951.161.371.591.80
OPK 1D NASDAQ O1.63H1.64L1.59C1.62-0.01 (-0.92%)Vol1.04M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
Ticker Type Headline Source Published
OPKOPKO Health, Inc. Press release OPKO Health to Report Third Quarter 2026 Financial Results on November 4, 2026 GlobeNewswire
OPKOPKO Health, Inc. Press release OPKO Health’s OPKO Biologics Doses First Participant in Phase 1/2a Trial of OPK-8801001 for Acromegaly GlobeNewswire
OPKOPKO Health, Inc. Stock news Crude Oil Moves Higher; Charles Schwab Shares Fall After Q3 Results Benzinga
OPKOPKO Health, Inc. Stock news OPKO Health Sheds Diagnostics Businesses in Major Labcorp Deal Benzinga
OPKOPKO Health, Inc. Press release Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and OPKO Health, Inc. (Nasdaq: OPK), a multinational... PR Newswire
OPKOPKO Health, Inc. Stock news Here's Why You Should Retain OPK Stock in Your Portfolio for Now Zacks Investment Research
OPKOPKO Health, Inc. Stock news OPK Stock Climbs 32.5% YTD: What's Driving the Rally in 2026? Zacks Investment Research
OPKOPKO Health, Inc. Stock news OPKO Health Pivots to Therapeutics, Eyes Data-Rich 12 to 18 Months MarketBeat
OPKOPKO Health, Inc. Stock news Analyzing HCA Healthcare (NYSE:HCA) & OPKO Health (NASDAQ:OPK) Defense World
OPKOPKO Health, Inc. Press release OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference GlobeNewswire
OPKOPKO Health, Inc. Stock news Why Is OPKO Health (OPK) Down 9.7% Since Last Earnings Report? Zacks Investment Research
OPKOPKO Health, Inc. Stock news Here's Why You Should Retain OPK Stock in Your Portfolio for Now Zacks Investment Research
OPKOPKO Health, Inc. Stock news OPK Raises $125 Million Against Royalties: What Investors Should Know Zacks Investment Research
OPKOPKO Health, Inc. Stock news Is OPK Worth Buying as Valuation Meets Improving Business Trends? Zacks Investment Research
OPKOPKO Health, Inc. Stock news OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going? Zacks Investment Research
OPKOPKO Health, Inc. Stock news OPKO Health Secures $125 Million Financing Against Mazdutide Royalties Zacks Investment Research
OPKOPKO Health, Inc. Press release OPKO Health Expands Strategic Relationship with HealthCare Royalty Through $125 Million Notes Issuance Secured by Mazdutide Royalty Interests GlobeNewsWire
OPKOPKO Health, Inc. Stock news OPKO Health: Mazdutide And MDX-2201 Could Change Everything Seeking Alpha
OPKOPKO Health, Inc. Stock news OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know Zacks Investment Research
OPKOPKO Health, Inc. Press release Cocrystal Pharma Announces $5 Million Private Placement with OPKO Health GlobeNewsWire
See more
FAQ

Questions about OPKO Health, Inc.

What does OPKO Health, Inc. do?
OPKO Health, Inc. is a healthcare company operating in diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. Its Diagnostics segment operates BioReference Laboratories, which provides laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare services to physician offices, clinics, hospitals, employers, and governmental units. It also offers a novel diagnostic instrument system for point-of-care blood test results and 4Kscore prostate cancer testing services.
What is OPK's market cap?
OPKO Health, Inc. (OPK) is a listed stock with a live quote. The latest market cap on this page is $1.2B.
Where is OPKO Health, Inc. headquartered?
OPKO Health, Inc. is headquartered in Miami, FL.
How do I get OPK news from the API?
Call GET /v1/news?tickers=OPK. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does OPK news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for OPK, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the OPK price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 1,000 REST requests a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs